Anzeige
Mehr »
Donnerstag, 03.07.2025 - Börsentäglich über 12.000 News
+210 % Kursgewinn Year to Date: Neuausrichtung nimmt Fahrt auf - jetzt exklusives CEO-Interview ansehen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
31 Leser
Artikel bewerten:
(0)

Implantable Cardiac Monitors Market to Reach a Market Size of $714.4 Million by 2024 - KBV Research

NEW DELHI, Feb. 21, 2019 /PRNewswire/ -- According to a new report Global Implantable Cardiac Monitors Market, published by KBV research, The Global Implantable Cardiac Monitors Market size is expected to reach $714.4 million by 2024, rising at a market growth of 7.6% CAGR during the forecast period. The factors that drive the growth of the implantable cardiac monitors market are technological advancements in cardiac monitor devices such as miniaturization and easier implant procedures, growing demand for implantable cardiac monitors to continuously monitor heart to detect cardiac arrhythmias and atrial fibrillation.

KBV_Research_Logo

The North America market would dominate the Global Cardiac Arrhythmias Market by Region by 2024, growing at a CAGR of 6.3 % during the forecast period. Favorable reimbursement policies and prominent market players operating in the region are the factors that drive the market growth herein. The Europe market is expected to witness a CAGR of 6.7% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 8.4% during (2018 - 2024).

Access Full Report: https://www.kbvresearch.com/implantable-cardiac-monitors-market/

The Hospitals market dominated the Global Implantable Cardiac Monitors Market by End User 2017 and would grow at a CAGR of 7.1 % during the forecast period. The Ambulatory Surgery Centers (ASCs) market is expected to witness a CAGR of 8% during (2018 - 2024). Cardiac centers & clinics segment would grow high CAGR during the forecast period. The growth in the segment is due to advantages of cardiac centers & clinics such as limited stay after surgical procedures and cost-effective treatments for cardiac related ailments.

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma Inc., Biotronik SE & Co. KG, Agilent Technologies, Inc., Berlin Heart GmbH, Schiller AG, Jarvik Heart, Inc.

Global Implantable Cardiac Monitors Market Segmentation

By Indication

  • Cardiac Arrhythmias
  • Atrial Fibrillation
  • Epilepsy & Unexplained falls

By End User

  • Hospitals
  • Ambulatory Surgery Centers (ASCs)
  • Cardiac Center & Clinics

By Geography

-North America

o US

oCanada

oMexico

o Rest of North America

-Europe

oGermany

o UK

oFrance

oRussia

oSpain

oItaly

o Rest of Europe

-Asia Pacific

oChina

oJapan

oIndia

oSouth Korea

oSingapore

oMalaysia

o Rest of Asia Pacific

- LAMEA

oBrazil

oArgentina

o UAE

oSaudi Arabia

oSouth Africa

oNigeria

o Rest of LAMEA

Companies Profiled

  • Abiomed, Inc.
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Reliant Heart, Inc.
  • Astellas Pharma inc.
  • Biotronik SE & Co. KG
  • Agilent Technologies, Inc.
  • Berlin Heart GmbH
  • Schiller AG
  • Jarvik Heart, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

  • Cardiac Pacemakers Market
  • Remote Patient Monitoring Devices Market
  • Neurovascular Devices Market
  • Ventricular Assist Devices Market

About Us:

Knowledge Based Value Research is a global brand and consulting firm serving all kinds of business verticals, government and non-governmental organizations, and not-for-profit organizations. Our motto is to extend our services that will have a lasting impact on our clients who trust us with their business goals.

Our aim is to transform and customize our services to address the fast changing business needs of our clients. With innovative methods, we seek to empower our research tools with new capabilities that would eventually bring about customer delight, as we understand that businesses evolve.

Contacts:

Mr. Alan D'Souza
KBV Research
244 Fifth Avenue, Suite 1407
New York, N.Y. 10001
United States (U.S)
Tel: +1 (646) 661-6066
Email: query@kbvresearch.com

© 2019 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.